Study guide
3.1 Medical Microbiology
NABP FPGEE Foreign Pharmacy Graduate Equivalency Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the FPGEE 1.2 How to Use This Study Guide
2 Chapter 2: Foundational Biomedical Sciences I
2.1 Anatomy 2.2 Physiology 2.3 Biochemistry
3 Chapter 3: Foundational Biomedical Sciences II
3.1 Medical Microbiology 3.2 Immunology 3.3 Pathophysiological Bases of Diseases
4 Chapter 4: Pharmaceutical Calculations, Compounding, and Medicinal Chemistry
4.1 Pharmaceutical Calculations 4.2 Extemporaneous Compounding 4.3 Physicochemical Properties, ADME, and Drug Metabolism Pathways 4.4 Structure-Activity Relationships and Drug-Receptor Interactions
5 Chapter 5: Pharmacology and Toxicology
5.1 Pharmacodynamics and Dose-Response 5.2 Mechanisms of Action of Drugs and Biologics 5.3 Adverse Effects, Side Effects, and Drug Interactions 5.4 Toxicology and Antidotes
6 Chapter 6: Pharmaceutics, Biopharmaceutics, and Pharmacokinetics
6.1 Dosage Forms, Drug Delivery, and Dissolution 6.2 Stability, Shelf-Life, and Manufacturing 6.3 ADME Rates, Half-Lives, and Compartment Models 6.4 Bioavailability, Bioequivalence, Biosimilars, and Pharmacogenomics
7 Chapter 7: Pharmacy Law, Ethics, and Health Care Systems
7.1 Pharmacy Law and Regulations 7.2 Ethics and Regulatory/Oversight Organizations 7.3 US Health Care Systems 7.4 Pharmacoeconomics
8 Chapter 8: Public Health, Practice Management, and Biostatistics
8.1 Pharmacoepidemiology, Population-Based Care, and Public Health 8.2 Practice Management 8.3 Continuous Quality Improvement, Risk Management, and Inventory Control 8.4 Biostatistics and Research Methods
9 Chapter 9: Professional Communication and Behavioral Aspects
9.1 Professional Communication 9.2 Social and Behavioral Aspects of Practice
10 Chapter 10: Clinical Sciences I — Pathophysiology and Patient Assessment
10.1 Clinical Pathophysiology: Cardiovascular and Endocrine 10.2 Clinical Pathophysiology: Respiratory, GI, Renal, and Other Systems 10.3 Patient Data Collection 10.4 Patient Data Assessment 10.5 Patient-Care Decision Making, Therapy Recommendations, and Education
11 Chapter 11: Clinical Sciences II — Patient Safety, Prevention, and Personalized Care
11.1 Patient Safety: Drug Interactions and Toxicity 11.2 Drug-Induced Disease and Drug Use Disorders 11.3 Disease Prevention 11.4 Personalized Medicine
12 Chapter 12: Clinical Sciences III — Evidence-Based Practice
12.1 Practice Guidelines and Drug Information 12.2 Clinical Trial Evaluation and Information Source Reliability
13 Chapter 13: Clinical Sciences IV — Self-Care and Natural Products
13.1 Self-Care and Natural Products
3.1 Medical Microbiology
Key Takeaways Explain This Topic AI
Gram-positive bacteria have thick peptidoglycan with teichoic acids; gram-negative bacteria have thin peptidoglycan plus an outer membrane containing lipopolysaccharide (LPS) endotoxin.
Antibiotic targets include cell wall synthesis (beta-lactams, vancomycin), 30S and 50S ribosomes (aminoglycosides, tetracyclines, macrolides), DNA gyrase (fluoroquinolones), folate metabolism (sulfonamides, trimethoprim), and the cell membrane (polymyxins).
Resistance spreads through beta-lactamases (including ESBLs and carbapenemases), altered targets (MRSA PBP2a), efflux pumps, porin loss, and biofilm formation, often transferred by plasmids and transposons.
Common respiratory pathogens are Streptococcus pneumoniae and Haemophilus influenzae; UTI pathogens are E. coli and Klebsiella; skin pathogens are Staphylococcus aureus (including MRSA) and Streptococcus pyogenes.
Clostridioides difficile overgrows after gut flora disruption by antibiotics such as clindamycin and fluoroquinolones, causing toxin-mediated pseudomembranous colitis.
Last updated: July 2026
Medical microbiology examines the bacteria, viruses, fungi, and parasites that cause human disease and the antimicrobial agents used to treat them. For the FPGEE, you need a working knowledge of microbial structure, classification, pathogenesis, and resistance — Domain 1 of the NABP Content Outline pairs these concepts with immunology and pathophysiology to form the foundational biomedical sciences.
Bacterial Structure and Classification
Bacteria are prokaryotes that lack a nucleus. The gram stain divides them into two large groups based on cell-wall composition. Gram-positive organisms retain crystal violet and appear purple because they have a thick peptidoglycan layer (20 to 80 nm) with teichoic acids woven through it. Gram-negative organisms lose the stain and appear pink; they have a thin peptidoglycan layer (2 to 7 nm) surrounded by an outer membrane containing lipopolysaccharide (LPS) , an endotoxin that triggers fever and septic shock when released during bacterial death.
- Feature Gram-Positive Gram-Negative
- Peptidoglycan Thick (20 to 80 nm) Thin (2 to 7 nm)
- Outer membrane Absent Present
- LPS endotoxin Absent Present
- Teichoic acids Present Absent
- Common examples Staphylococcus, Streptococcus, Bacillus E. coli, Salmonella, Pseudomonas
Common shapes are cocci (spheres), bacilli (rods), and spirochetes (spirals). Atypical bacteria include Mycoplasma (no cell wall, unaffected by beta-lactams) and Chlamydia and Rickettsia (obligate intracellular pathogens).
Viruses
Viruses are acellular entities consisting of nucleic acid (DNA or RNA) wrapped in a protein capsid ; some add a lipid envelope derived from host membranes. Replication follows the stages of attachment, penetration, uncoating, biosynthesis, assembly, and release. Lytic cycles destroy the host cell; lysogenic cycles integrate viral DNA into the host genome. In human disease, latency allows viruses such as herpes simplex (HSV), varicella-zoster (VZV), and HIV to persist in dormant form and reactivate later. Oncogenic viruses (HPV, EBV, HBV, HTLV-1) drive malignant transformation through oncogene expression or tumor-suppressor inhibition.
Fungi
Fungi are eukaryotes. Yeasts are single-celled; molds grow as branching hyphae. Dimorphic fungi switch forms depending on temperature — Histoplasma, Blastomyces, and Coccidioides grow as molds in the environment at 25 degrees C and as yeasts in tissue at 37 degrees C. Opportunistic mycoses such as Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus cause disease when host immunity falters. Fungal cell walls contain ergosterol , the target of polyene antifungals (amphotericin B) and azole antifungals (fluconazole, voriconazole).
Parasites
Protozoa are single-celled eukaryotes (Plasmodium, Giardia, Toxoplasma, Trichomonas). Helminths are multicellular worms grouped as nematodes, cestodes, and trematodes. Ectoparasites such as lice and scabies mites live on the skin. Antiparasitic therapy targets unique features: aminoquinolines block heme polymerization in malaria; benzimidazoles disrupt helminth microtubules; ivermectin opens parasite glutamate-gated chloride channels.
Normal Flora and Opportunistic Infection
The skin, gut, vagina, and respiratory tract host resident normal flora that compete with pathogens and prime the immune system. Disruption by antibiotics, catheters, or immunosuppression lets opportunists such as Candida , Clostridioides difficile , and coagulase-negative staphylococci overgrow. C. difficile is the classic antibiotic-associated colitis pathogen, releasing toxins A and B that cause pseudomembranous colitis.
Antimicrobial Targets and Resistance
Antibiotics exploit selective toxicity against bacterial structures absent from human cells:
Cell wall synthesis — beta-lactams (penicillins, cephalosporins, carbapenems) bind penicillin-binding proteins; vancomycin binds D-Ala-D-Ala.
Protein synthesis — aminoglycosides and tetracyclines act at the 30S subunit; chloramphenicol, macrolides, and clindamycin act at the 50S subunit.
DNA and RNA synthesis — fluoroquinolones inhibit DNA gyrase and topoisomerase IV; rifampin inhibits bacterial RNA polymerase.
Folate metabolism — sulfonamides and trimethoprim block sequential steps in tetrahydrofolate synthesis.
Cell membrane — polymyxins (colistin) disrupt the gram-negative outer membrane.
Resistance mechanisms include beta-lactamases (which hydrolyze the beta-lactam ring; extended-spectrum beta-lactamases and carbapenemases extend the spectrum), altered targets (MRSA's PBP2a; mutated ribosomes), efflux pumps (tetracycline and fluoroquinolone export), reduced permeability through porin loss, and biofilm formation (protected communities on catheters and heart valves). Horizontal gene transfer via plasmids, transposons, and bacteriophages spreads resistance between organisms and across species.
Key Pathogens by Body System
Respiratory: Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, plus respiratory viruses.
Gastrointestinal: Escherichia coli (ETEC, EHEC), Salmonella, Shigella, Campylobacter, C. difficile.
Urinary tract: E. coli (most common), Klebsiella, Proteus, Enterococcus.
Skin and soft tissue: Staphylococcus aureus (including MRSA), Streptococcus pyogenes.
Bacteremia and sepsis: S. aureus, E. coli, Klebsiella, Pseudomonas aeruginosa.
Loading diagram...